About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 440 record(s)
Req # A-2023-000499
Adverse Drug Reactions (ADRs). Report numbers: 001041172, 001041389, 001042026, 001042044.Organization: Health Canada
July 2023
Req # A-2023-00010
OSFI recently issued a press release entitled "Update to LAR guideline review for wholesale funding sources with retail-like characteristics" (https://www.osfi-bsif.gc.ca/Eng/fi-if/in-ai/Pages/hisa-ceie-20230719-let.aspx). In the press release, OSFI indicated that it had received 175 submission to the public consultation. I would like PDF copies of each submissionOrganization: Office of the Superintendent of Financial Institutions Canada
July 2023
Req # A-2023-00009
From January 1 2021 to July 6 2023, requesting all contracts with the "KOJO Institute" (final contract only, no drafts), all reports filed in accordance with the contract, all training materials provided in accordance with the contract, any recordings of the training sessions (written, audio, or video)Organization: Office of the Superintendent of Financial Institutions Canada
July 2023
Req # A-2016-001921
All records as it pertains to Natural Product Number (NPN) 80043184 (Dove Cleartone)Organization: Health Canada
July 2022
Req # A-2017-001094
All documents from October 1, 2017 to November 16, 2017 that mention a tax on sugar or fat, a fat tax, a sugar tax, a sugar-sweetened beverage tax (SSB tax), soft drink tax, soda tax, or junk food taxOrganization: Health Canada
July 2022
Req # A-2017-001792
The most recent Drug Establishment Licence for Auro Pharma including any annexes listing foreign buildings and the drugs they are licensed to produce.Organization: Health Canada
July 2022
Req # A-2018-000383
All reviewers' reports regarding the cleared Supplement to a New Drug Submission (SNDS) for the pre-filled syringe presentation.Organization: Health Canada
July 2022
Req # A-2018-000944
All documents describing any and all features of the "class exemption" issued by the Minister of Health under s. 56 of the Controlled Drugs and Substances.Organization: Health Canada
July 2022
Req # A-2018-000999
All correspondence sent by Health Canada to Teva Pharmaceuticals USA between January 1, 1996 to January 1, 1998, with respect to the new drug submission for glatiramer acetate (tradename: COPAXONE, NDS 044430, rec. 1996-07-12), Notice of Compliance date 1997-09-04.Organization: Health Canada
July 2022
Req # A-2019-000581
Any correspondence between Johnson and Johnson and Health Canada related to vapour products, vaping products, electronic cigarettes and electronic nicotine delivery systems, from January 1, 2017 to July 18, 2019.Organization: Health Canada
July 2022